People with diabetes are well aware that in order to effectively manage their diabetes, they need blood glucose measurements to make various decisions. This, in turn, involves repeatedly pricking their fingertips throughout the day. Therefore, they are looking for a variety of ways to improve their quality of life. Due to its many advantages, continuous glucose monitoring systems have been gaining popularity in recent years. In September, the next-generation Eversense®E3 continuous glucose monitoring system with an implanted sensor, designed for long-term wear, appeared on the Polish market. It makes living with diabetes easier.
Why does a person with diabetes need to control blood sugar levels?
To effectively manage your diabetes, it is recommended that you check your blood glucose levels several times a day. An intense pace of life or the desire to play sports make this a nuisance. Long-term high blood sugar caused by uncontrolled diabetes contributes to inflammation and changes at the cellular level, which promotes the development of diabetes complications. In contrast, maintaining normal blood sugar levels not only affects health, but also reduces the risk of such complications as kidney and eye disease, heart failure, stroke and poor circulation in the extremities.
Eversense® E3 continuous glucose monitoring system offers freedom not offered by other CGM systems
The Eversense E3 is a fully implantable, long-term CGM system designed to build on the unique benefits users experienced with the previous version of the Eversense® XL system.
Among other commercially available CGM systems, the Eversense E3 stands out for having the highest accuracy (MARD of 8.5%) and sensor durability for 6 months of use.
It also offers the ability to make therapeutic decisions e.g., in insulin dosing situations, without the need to confirm blood glucose levels with a fingertip measurement. The frequency of calibration has also been reduced, typically 1 per day after day 21 of use.
– “We are pleased that Eversense E3 is also available in Poland, as it will make life easier for more people with diabetes. As a long-term CGM system, Eversense E3 gives them the freedom that other CGM systems do not offer. This is a significant qualitative change for patients-with unique features that provide exceptional accuracy, convenience and flexibility.” – emphasizes Torstein Myhre, head of the EU region at Ascensia Diabetes Care.
Advantages of using the enhanced Eversense E3 CGM system:
- convenience in the long run, one sensor for 6 months
- Stable accuracy that also provides peace of mind in case of hypoglycemia
- patches gentle on the skin, replaced daily
- Flexibility of use with easily attachable and removable transmitter, no risk of losing the sensor
- discreet alarms with vibrations felt on the skin in case of hypo or hyperglycemia – waterproof transmitter that can be submerged in water, which means you don’t have to take it off while swimming
